Geyser Brands Inc. (TSX.V: GYSR) Sees Global Opportunities in Growing Portfolio of Health-Focused CBD, Hemp Product Lines

  • Geyser Brands continues to strengthen its leadership team with industry leaders
  • The company’s proprietary nanotechnology formulations transport therapeutic agents with superior bioavailability and efficacy
  • Geyser Brands is pursuing the acquisition of Solace Management Group, solidifying its place as a leading provider of health-focused CBD and hemp products

Geyser Brands Inc. (TSX.V: GYSR), a global science-led consumer health care company, builds and markets some of the world’s leading cannabis products and brands. As a licensed producer in Canada under the Cannabis Act, Geyser operates a production and processing facility in Port Coquitlam, British Columbia, developing unique products for healthy lifestyle brands (http://cnw.fm/SdE7g).

One of Geyser’s wholly owned subsidiaries, Apothecary Botanicals, recently received a standard processing license from Health Canada. Receipt of the license was heralded by Geyser CEO Andreas Thatcher as “a huge milestone” for the company.

“The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,” Thatcher stated in a news release (http://cnw.fm/8FyOi). “It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.”

The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its R&D and sales licenses. Physical modifications to the Apothecary Botanicals manufacturing facility to deliver GMP-compliant capacity are complete, with production of in-house formulated branded products expected to begin sometime in late summer.

With the completion of its proposed Solace Management Group acquisition, Geyser intends to increase its production capacity with another GMP facility dedicated to hemp-related human and pet products. These products already feature the proprietary nanotechnology for stronger, more stable offerings. The intention is to extend the Solace product and formulations into the regulated cannabis space through Geyser’s licensed producer.

Adding strength to the company’s endeavors is the recent addition of several seasoned industry leaders to its management team (http://cnw.fm/CzA14). Joining the board of directors is Dr. Bin Huang, a seasoned life sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia.

Chartered Professional Accountant Gordon Clissold, who has over 20 years of experience as an operational and financial manager for both public and private companies, has been named chief financial officer. Clissold has also served as a past president of the Certified General Accountants of BC. These pivotal appointments to Geyser Brands’ leadership team are expected to bring valuable oversight and experience to the company as it pursues strategic goals in 2019 and beyond.

In combination with its proposed acquisition of Solace Management Group, these additions are expected to play a key role in establishing Geyser Brands as a leading provider of health-focused CBD and hemp products (http://cnw.fm/N3fHV).

For more information, visit the company’s website at www.GeyserBrands.com

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.canadiancannabiswire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.canadiancannabiswire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

Archives

Select A Month

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977